My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 627

    1.

    PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.

    van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM, Pijl H.

    Diabetes. 2004 Aug;53(8):1949-52.PMID: 15277371 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.

    van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP, Pijl H.

    Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E238-45. Epub 2006 Aug 29.PMID: 16940471 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.

    Oakes ND, Thalén PG, Jacinto SM, Ljung B.

    Diabetes. 2001 May;50(5):1158-65.PMID: 11334421 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.

    van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, Pijl H.

    Diabetes. 2004 Oct;53(10):2529-34.PMID: 15448080 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice.

    Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Granner DK, Wasserman DH.

    Diabetes. 2004 Feb;53(2):306-14.PMID: 14747279 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.

    de Souza CJ, Hirshman MF, Horton ES.

    Diabetes. 1997 Aug;46(8):1257-63.PMID: 9231648 [PubMed - indexed for MEDLINE]Related articles

    7.

    Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.

    Parlevliet ET, Heijboer AC, Schröder-van der Elst JP, Havekes LM, Romijn JA, Pijl H, Corssmit EP.

    Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E142-7. Epub 2007 Oct 30.PMID: 17971509 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

    Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW.

    Diabetes. 1994 Oct;43(10):1203-10.PMID: 7926289 [PubMed - indexed for MEDLINE]Related articles

    9.

    PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.

    Adams SH, Lei C, Jodka CM, Nikoulina SE, Hoyt JA, Gedulin B, Mack CM, Kendall ES.

    J Nutr. 2006 Jan;136(1):195-201.PMID: 16365082 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat.

    Jucker BM, Rennings AJ, Cline GW, Shulman GI.

    J Biol Chem. 1997 Apr 18;272(16):10464-73.PMID: 9099689 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.

    Parlevliet ET, Schröder-van der Elst JP, Corssmit EP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H.

    J Pharmacol Exp Ther. 2009 Jan;328(1):240-8. Epub 2008 Oct 10.PMID: 18849357 [PubMed - indexed for MEDLINE]Related articles

    12.

    High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.

    Li L, Yang G, Li Q, Tang Y, Li K.

    Ann Nutr Metab. 2006;50(6):499-505. Epub 2006 Dec 21.PMID: 17191023 [PubMed - indexed for MEDLINE]Related articles

    13.

    Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

    Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC.

    PLoS One. 2009;4(3):e4937. Epub 2009 Mar 19.PMID: 19295913 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA.

    Oakes ND, Bell KS, Furler SM, Camilleri S, Saha AK, Ruderman NB, Chisholm DJ, Kraegen EW.

    Diabetes. 1997 Dec;46(12):2022-8.PMID: 9392490 [PubMed - indexed for MEDLINE]Related articles

    15.

    Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.

    Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, Couzens M, Slack K, Dallmann R, Sainsbury A, Herzog H.

    Diabetologia. 2006 Jun;49(6):1360-70. Epub 2006 Apr 21.PMID: 16680491 [PubMed - indexed for MEDLINE]Related articles

    16.

    Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.

    Magnan C, Gilbert M, Kahn BB.

    Lipids. 1996 Nov;31(11):1141-9.PMID: 8934446 [PubMed - indexed for MEDLINE]Related articles

    17.

    A fish oil diet does not reverse insulin resistance despite decreased adipose tissue TNF-alpha protein concentration in ApoE-3*Leiden mice.

    Muurling M, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ.

    J Nutr. 2003 Nov;133(11):3350-5.PMID: 14608043 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.

    Irwin N, Hunter K, Flatt PR.

    Peptides. 2007 Nov;28(11):2192-8. Epub 2007 Aug 19.PMID: 17884253 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats.

    Vettor R, Pagano C, Granzotto M, Englaro P, Angeli P, Blum WF, Federspil G, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1998 Nov;41(11):1361-7.PMID: 9833945 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II.

    Fueger PT, Lee-Young RS, Shearer J, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH.

    Diabetes. 2007 Oct;56(10):2476-84. Epub 2007 Jul 16.PMID: 17639019 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity